Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age25-50
SponsorEge University

About this trial

Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction.

For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.

Eligibility criteria

Qualifiers

Female patients aged 25-50 years

Literate and able to comprehend written and spoken instructions

Diagnosed with relapsing-remitting form of multiple sclerosis

Having a continuous/regular sexual partner

Disqualifiers

Pregnancy

Illiteracy or inability to understand spoken or written instructions

Absence of a continuous/regular sexual partner

Expanded Disability Status Scale (EDSS) score > 5

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators